CareRx Corporation

Total Valuation

CareRx Corporation carries a market capitalization of 150.37M, placing it among publicly traded companies globally. Its enterprise value stands at 278.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

CareRx Corporation currently has 63.45M shares outstanding.

Valuation Ratios

CareRx Corporation trades at a trailing price-to-earnings ratio of 8.32. The price-to-sales ratio is 0.74, and the price-to-book ratio stands at 1.93.

Enterprise Valuation

On an enterprise value basis, CareRx Corporation trades at an EV/EBITDA multiple of 12.15 and an EV/FCF ratio of 4.26. The EV/Sales ratio of 0.98 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 29.57 provides insight into valuation relative to core operating earnings.

Financial Position

CareRx Corporation maintains a current ratio of 1.08, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 69.65, indicating elevated leverage, while an interest coverage ratio of 4.72 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, CareRx Corporation has paid -22.02M in income taxes, reflecting an effective tax rate of 66.94.

Stock Price Statistics

CareRx Corporation's stock has gained approximately 8.7156% over the past 52 weeks. The 50-day moving average sits at 2.40, while the 200-day moving average is 2.59.

Income Statement

Over the trailing twelve months, CareRx Corporation generated 283.58M in revenue and converted that into 25.32M in net income, yielding earnings per share of 0.39. EBITDA reached 22.92M, while operating income came in at 9.41M.

Balance Sheet

CareRx Corporation holds 9.57M in cash and equivalents against 76.34M in total debt, resulting in a net debt position of 29.09M. Total book value stands at 109.60M, with working capital of 4.70M providing operational flexibility.

Cash Flow

CareRx Corporation produced 20.21M in operating cash flow over the past twelve months. After subtracting -7.89M in capital expenditures, free cash flow totaled 12.32M - equivalent to 0.20 per share.

Margins

CareRx Corporation operates with a gross margin of 29.97, reflecting its pricing power and cost economics. The operating margin of 3.32 and net profit margin of 8.93 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 14.95 indicates the proportion of earnings distributed to shareholders.

Stock Splits

CareRx Corporation's most recent stock split took place on June 25, 2020 with a 20:1 split ratio.

Scores

CareRx Corporation posts an Altman Z-Score of 0.60, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.